Evidence map›Paper›PMID 42698744›Full record

ArticleRespirology case reports2026

A Rare Case of COPA Syndrome: Multisystem Relapse and Fatal Septic Complication.

Flavia Castro Velasco Fernandes, Pedro Paulo Teixeira E Silva Torres, Elisângela de Paula Silveira-Lacerda, Matheus Rabahi, Lucas Velasco Magalhaes Fernandes, Laís Rocha Lopes, Marise Amaral Rebouças Moreira, Marcelo Fouad Rabahi

Abstract read
In one paragraph

Article in Respirology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Flavia Castro Velasco FernandesFaculdade de Medicina, Universidade Federal de Goiás Goiânia Brazil.ORCID https://orcid.org/0000-0002-5973-2877
Pedro Paulo Teixeira E Silva TorresHospital Israelita Albert Einstein Goiânia Goiás Brazil.ORCID https://orcid.org/0000-0002-8571-5667
Elisângela de Paula Silveira-LacerdaInstituto de Ciências Biológicas, Universidade Federal de Goiás Goiânia Brazil.ORCID https://orcid.org/0000-0002-4143-9007
Matheus RabahiFaculdade de Medicina, Universidade Federal de Goiás Goiânia Brazil.
Lucas Velasco Magalhaes FernandesLake Erie College of Osteopathic Medicine Bradenton Florida USA.ORCID https://orcid.org/0009-0003-6923-4008
Laís Rocha LopesFaculdade de Medicina, Universidade Federal de Goiás Goiânia Brazil.ORCID https://orcid.org/0009-0002-6089-0482
Marise Amaral Rebouças MoreiraDepartment of Pathology Universidade Federal de Goiás Goiânia Brazil.
Marcelo Fouad RabahiFaculdade de Medicina, Universidade Federal de Goiás Goiânia Brazil.ORCID https://orcid.org/0000-0002-4050-5906

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COPA syndrome is a rare autosomal dominant autoimmune disorder caused by COPA gene mutations, leading to immune dysregulation and multisystem involvement. We report a 45-year-old man with recurrent respiratory failure, haemoptysis, renal dysfunction and arthritis. Symptoms began at Age 27 with diffuse alveolar damage requiring mechanical ventilation. Imaging showed progressive interstitial lung disease and biopsy revealed follicular bronchiolitis. Immunosuppression provided temporary stabilisation. In 2024, next-generation sequencing confirmed a likely pathogenic COPA variant. The patient later discontinued therapy and remained untreated for 1 year, returning with worsening renal dysfunction and significant proteinuria, while pulmonary findings remained stable. Cyclophosphamide was initiated for suspected renal relapse. During treatment, he developed acute diverticulitis complicated by sepsis, progressing to septic shock and multiorgan failure despite surgery and antibiotics, resulting in death. Early recognition and multidisciplinary management are essential to improve outcomes of the disease.

Indexed as

COPA syndrome; autoimmune disordergene mutationinterstitial lung disease

Identifiers

PMID42698744
PMCPMC13541764

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.